Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury

Guodong Shi1, Yang Liu, Tielong Liu

  • 1Department of Orthopaedics, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, People's Republic of China.

Experimental Brain Research
|November 19, 2011
PubMed

Insights

MicroRNAs (miRNAs) regulate cell survival. This study found miR-29b increases neuronal cell death in ischemic brain injury by targeting Bcl2L2, offering a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are critical regulators of cell survival.
  • The specific roles of miRNAs in ischemic brain injury are not well understood.

Purpose of the Study:

  • To investigate the role of miR-29b in ischemic brain injury.
  • To identify the target genes and biological functions of miR-29b.

Main Methods:

  • Assayed miR-29b expression levels in rat brains after middle cerebral artery occlusion and in neurons after oxygen-glucose deprivation.
  • Examined the effect of miR-29b overexpression and repression on neuronal cell death.
  • Identified and validated Bcl2L2 as a direct target gene of miR-29b.

Main Results:

  • miR-29b levels were significantly increased in ischemic brain tissue and oxygen-glucose deprived neurons.
  • Overexpression of miR-29b promoted neuronal cell death, while repression decreased it.
  • miR-29b directly inhibited Bcl2L2 expression, leading to increased neuronal death. Bcl2L2 overexpression rescued this effect.

Conclusions:

  • miR-29b plays a significant role in regulating neuronal cell death following ischemic injury.
  • miR-29b represents a potential therapeutic target for ischemic brain injury.